**Stakeholder-walkthrough readability: 8/10.**

Would walk room through this now. Front matter works: `At a Glance` gives problem, recommendation, Phase 1, blocker in one scan. `Decisions Needed From You` routes core decisions before detail. Big improvement for first 30 seconds.

Main PM strengths:

- Front matter separates orientation from reasoning. `§1 Executive Summary` now acts as summary, points readers to detail, avoids repeating argument.
- `§10.5` security bullets work well live. Can pause at token model, WebView bridge, recording, clinical-data auditability without losing room.
- `§8.5` decision bullets preserve reasoning. Decision 1 vs Decision 2 split prevents false “RN required because calling” conclusion. Strong stakeholder framing.
- `§11.1` table makes Phase 1 scope easy to present; exit criteria gives QA, Product, Medical clear checkpoints.
- `§13.2` table major walkthrough improvement. IDs make discussion trackable; rows support “OQ-New-7 belongs with Product/Telephony” better than 26 prose blocks.

Connective-reasoning check:

- Bullets mostly retain enough “why.” Best examples: `R1` problem → behaviour → taxonomy → permission → policy status → gate exception; `§8.5` decision → rationale → validation gate.
- Some claimed bullet conversions remain prose-heavy:
  - `§7.1` still one dense arrow-chain sentence. Fine for a spec, weaker spoken walkthrough.
  - `§8` evidence caveat remains one long paragraph. Important message, but hard to present without paraphrasing.
  - `§11.0` intro and closing dependency rule are dense; numbered validation steps themselves present well.
  - `§11.1` estimation-scope note is still a dense paragraph after otherwise scan-friendly table/bullets.
- No material loss of reasoning from bullets. Issue is residual dense bridges, not bullet over-compression.

Open Questions table: improvement, with caveat.

- Better live artifact: one row, one ID, one status/owner field. PM can assign follow-ups visibly.
- Weakness: `Status / Owner` merges two fields. Many rows lack named accountable owner (`OQ-001`, `OQ-002`, `OQ-003`, `OQ-005`, etc.). Cannot reliably say “this one is yours” for every row.
- Flat list removes prior thematic grouping. Good for tracking; less good for discussion order. PM must narrate groups: clinical/compliance, operating model, telephony/platform, security.
- Some nuanced rows retain enough context (`OQ-New-12`, `OQ-New-13`); short rows like `OQ-002` need linked section opened during actual decision, not resolved from table alone.

Remaining meeting-readiness gap: routing table does not explicitly route Design, Frontend, QA, or React Native as distinct stakeholders; “Mobile platform owner” and “Backend/Telephony eng” cover some, QA absent. Also user list contains nine stakeholder groups, not eight.

Bottom line: confident for walkthrough now. Start with front matter, use `§11` for scope/sequence, then route by `§13.2` IDs. Keep `§7.1`, `§8` caveat, and `§11.0/11.1` dense bridge paragraphs as presenter notes rather than reading them aloud.